A Phase 1, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PRAX-114 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs PRAX-114 (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Praxis Precision Medicines
- 01 Feb 2019 Status changed from recruiting to completed.
- 09 Jul 2018 Status changed from not yet recruiting to recruiting.
- 04 May 2018 New trial record